Mead Johnson Nutrition CO  

(Public, NYSE:MJN)   Watch this stock  
Find more results for James Johnson´┐Ż
+0.04 (0.05%)
Real-time:   3:11PM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 79.08 - 80.90
52 week 69.20 - 105.45
Open 80.35
Vol / Avg. 2.15M/2.90M
Mkt cap 16.17B
P/E 23.90
Div/yield 0.41/2.05
EPS 3.37
Shares 202.80M
Beta 1.00
Inst. own 98%
Jan 27, 2016
Q4 2015 Mead Johnson Nutrition Co Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Oct 22, 2015
Mead Johnson Nutrition Co Investor Day - Webcast
Oct 22, 2015
Q3 2015 Mead Johnson Nutrition Co Earnings Release
Oct 22, 2015
Q3 2015 Mead Johnson Nutrition Co Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 15.82% 16.53%
Operating margin 23.12% 22.41%
EBITD margin - 24.54%
Return on average assets 16.03% 20.10%
Return on average equity 111.94% 165.92%
Employees 7,700 -
CDP Score - 92 B


2701 Patriot Blvd Fl 4
GLENVIEW, IL 60026-8039
United States - Map
+1-847-8322420 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.

Officers and directors

Peter Kasper Jakobsen President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Michel M.G. Cup Chief Financial Officer, Executive Vice President
Age: 45
Bio & Compensation  - Reuters
Charles M. Urbain Chief Operating Officer, Executive Vice President
Age: 61
Bio & Compensation  - Reuters
Patrick M. Sheller Senior Vice President, General Counsel, Secretary
Age: 53
Bio & Compensation  - Reuters
James Jeffrey Jobe Senior Vice President - Technical Operations
Age: 55
Bio & Compensation  - Reuters
Dirk Hondmann Ph.D. Chief Scientific Officer
Age: 51
Bio & Compensation  - Reuters
James M. Cornelius Non-Executive Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Stephen W. Golsby Director
Age: 60
Bio & Compensation  - Reuters
Elliott Sigal M.D., Ph.D. Director
Age: 63
Bio & Compensation  - Reuters
Steven M. Altschuler M.D. Independent Director
Age: 61
Bio & Compensation  - Reuters